Eisai Co., Ltd. (ESAIY)
7.64
+0.06
(+0.79%)
USD |
OTCM |
Aug 25, 16:00
Eisai Enterprise Value : 8.547B for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 8.547B |
| August 24, 2026 | 8.479B |
| August 21, 2026 | 8.694B |
| August 20, 2026 | 8.615B |
| August 19, 2026 | 8.671B |
| August 18, 2026 | 8.355B |
| August 17, 2026 | 8.276B |
| August 14, 2026 | 8.476B |
| August 13, 2026 | 8.502B |
| August 12, 2026 | 8.721B |
| August 11, 2026 | 8.694B |
| August 10, 2026 | 8.660B |
| August 07, 2026 | 8.457B |
| August 06, 2026 | 8.163B |
| August 05, 2026 | 7.960B |
| August 04, 2026 | 8.197B |
| August 03, 2026 | 8.106B |
| July 31, 2026 | 8.344B |
| July 30, 2026 | 8.784B |
| July 29, 2026 | 8.671B |
| July 28, 2026 | 8.186B |
| July 27, 2026 | 8.061B |
| July 24, 2026 | 7.937B |
| July 23, 2026 | 7.756B |
| July 22, 2026 | 7.745B |
| Date | Value |
|---|---|
| July 21, 2026 | 7.688B |
| July 20, 2026 | 7.598B |
| July 17, 2026 | 7.632B |
| July 16, 2026 | 7.485B |
| July 15, 2026 | 7.282B |
| July 14, 2026 | 7.462B |
| July 13, 2026 | 7.485B |
| July 10, 2026 | 7.406B |
| July 09, 2026 | 7.338B |
| July 08, 2026 | 7.349B |
| July 07, 2026 | 7.349B |
| July 06, 2026 | 7.440B |
| July 02, 2026 | 7.236B |
| July 01, 2026 | 7.033B |
| June 30, 2026 | 6.999B |
| June 29, 2026 | 7.250B |
| June 26, 2026 | 7.070B |
| June 25, 2026 | 6.900B |
| June 24, 2026 | 6.810B |
| June 23, 2026 | 6.788B |
| June 22, 2026 | 6.833B |
| June 18, 2026 | 6.946B |
| June 17, 2026 | 6.720B |
| June 16, 2026 | 6.606B |
| June 15, 2026 | 6.675B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 85.56B |
| Daiichi Sankyo Co., Ltd. | 31.72B |
| Chugai Pharmaceutical Co., Ltd. | 66.09B |
| Santen Pharmaceutical Co., Ltd. | 3.485B |
| Ono Pharmaceutical Co., Ltd. | 6.600B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 120.18M |
| Revenue (Quarterly) | 1.471B |
| Total Expenses (Quarterly) | 1.356B |
| EPS Diluted (Quarterly) | 0.1015 |
| Gross Profit Margin (Quarterly) | 78.20% |
| Profit Margin (Quarterly) | 8.17% |
| Earnings Yield | 3.18% |
| Operating Earnings Yield | 3.29% |
| Normalized Earnings Yield | 3.181 |